Credit Suisse Upgrades Abaxis Inc. (ABAX) to Neutral Following Acquisition
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Zoetis Inc. (ZTS) PT Raised to $82 at BMO Capital; Abaxis Deal Strong But Doesn't Change Thesis
May 17, 2018 1:06 PM EDTBMO Capital raised its price target on Zoetis Inc. (NYSE: ZTS) to $82.00 (from $80.00) while maintaining a Market Perform rating.
Analyst Alex Arfaei commented, "We have updated our model to include Abaxis acquisition. Overall, we see a strong strategic rationale for the... More
Zoetis (ZTS) to Acquire Abaxis (ABAX) for About $2 Billion
May 16, 2018 7:01 AM EDTZoetis Inc. (NYSE: ZTS) and Abaxis, Inc. (NASDAQ: ABAX) today announced a definitive merger agreement pursuant to which Zoetis will acquire Abaxis, a leader in the development, manufacture and marketing of diagnostic instruments for veterinary point-of-care services for US $83 per share in cash, or approximately $2.0 billion in aggregate. The acquisition is expected to enhance Zoetis presence in veterinary diagnostics, a category of the animal health industry with approximately 10% compound annual growth over the last three years1.
Abaxis, founded in 1989 and headquartered in Union City, Calif., is a... More
